Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action
{{output}}
Breast cancer is one of the most significant causes of mortality among women and the second most prevalent cancer worldwide. Estrogen receptor (ER)-positive breast cancers are the most common molecular subtype of breast cancer, comprising about 70% of breast c... ...
